why choose us

300×250 Ad Slot

Research Article: Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis

Date Published: 2023-11-20

Abstract:
Introduction: Psoriatic arthritis (PsA) is a complex and heterogeneous inflammatory disease. Secukinumab, a biologic disease-modifying antirheumatic drug (bDMARD), has extensive clinical evidence of efficacy and safety in the treatment of PsA but data in clinical practice are still limited. This study aims to provide real-world evidence on secukinumab use, effectiveness, and persistence in PsA.

No summary available.

300×250 Ad Slot